Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs VanEck Semiconductor ETF (SMH) Price & Performance

BridgeBio Pharma IncTrade
VanEck Semiconductor ETFTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs VanEck Semiconductor ETF — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while VanEck Semiconductor ETF trades at $582.75. Which is the better fit depends on your goals.

BBIOSMH
Market Cap
$16.61B
Sector
Health
52-Week High
$90.17$668.91
52-Week Low
$47.29$286.43
Enterprise Value
$18.16B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BridgeBio Pharma Inc

No Aura AI signal available yet.

VanEck Semiconductor ETF

SMH trades at $582.70, up 1.96% today, with a bullish technical signal from moving averages but a neutral stance from oscillators. The ETF faces mixed sentiment, with some analysts downgrading to Hold amid competition from income-focused alternatives like CHPY, while others highlight potential from sustained AI spending. Key support lies near $575, with resistance at $588.

Outlook remains cautiously optimistic given AI-driven semiconductor demand, but risks include market volatility and concentrated holdings. Institutional activity shows mixed signals, with recent large purchases offset by sales. The ETF's performance hinges on broader tech sector trends and semiconductor cycle dynamics.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About VanEck Semiconductor ETF

The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.

Read more on SMH